Endocrine Abstracts

Recent analysis has shown that up to 18 percent of the Irish population are obese; a further 40 percent are overweight. Orlistat (Xenical)is a gastrointestinal lipase inhibitor that limits absorption of ingested fat thus aiding weight reduction. We report the use of orlistat outside the clinical trial setting in Ireland from 7 April 2000 to 30 June 2001.A total of 5,251 patients (4,376 women, 875 men) attended 240 weight management clinics (229 in primary care and 11 in se...